Goat anti-APOE Antibody |
| Principle Name | APOE |
| Official Symbol | APOE |
| All Name and Symbols | APOE; AD2; MGC1571; apoprotein; apolipoprotein E; apolipoprotein E3; Alzheimer disease 2 (APOE*E4-associated, late onset); LPG |
| Accession Number(s) | NP_000032.1 |
| Peptide Sequence | VGTSAAPVPSDNH, is from C Terminus |
| Human Gene ID(s) | 348 |
| Non-Human GeneID(s) | |
| Important Comments | |
| Purification | Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide. |
| Supplied As | lyophilized powder of 50ug or 100ug IgG; Reconsititute IgG with 100ul or 200ul sterile DI Water and final product will be formulated as 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
Aliquot and store at -20°C. Minimize freezing and thawing. |
| Applications | Pep ELISA, WB |
| Tested Species | Human |
| Peptide ELISA | antibody detection limit dilution 1 to 2000. |
| Western Blot | Approx. 36kDa band observed in Human Brain lysates (calculated MW of 36.2kDa according to NP_000032.1). Recommended concentration |
| Reference(s) | Dodart JC, Marr RA, Koistinaho M, Gregersen BM, Malkani S, Verma IM, Paul SM. Gene delivery of human apolipoprotein E alters brain A{beta} burden in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A. 2005 Jan 25;102(4) |
